Internal Medicine
333 Cedar Street
Room LMP-1072
P.O. Box 208056
New Haven, CT 06520-8056

Associate Professor of Medicine
Associate Chief, VACHS Medical Service
Director, Hypertension Clinic, VA Connecticut Healthcare System
Section of Nephrology
I am a nephrologist with a subspecialty title in Clinical Hypertension. Thus, my most distinctive expertise is in hypertension diagnosis and management, with a special focus on refractory hypertension, renovascular hypertension, and primary aldosteronism. In addition, I am a clinical nephrologist with a broad interest in acute and chronic consultative nephrology.
My research interests address the interplay between hypertension, the kidney and the vasculature. Because hypertension is a major comorbidity in patients with chronic kidney disease, I have focused my research on efforts to understand the behavior of blood pressure in hemodialysis patients with emphasis on ambulatory BP monitoring and on the evaluation of systemic hemodynamics and body fluid compartments. More recently, we have moved to clinical trials with a focus on modifications in dialysate sodium delivery to improve BP control (clinicaltrials.gov identifiers NCT00259714 and NCT00237783).
A very important factor in the pathogenesis of hypertension in kidney disease is arterial stiffness. I have used non–invasive methods to assess arterial stiffness (analysis of pulse wave morphology and reflection, pulse wave velocity) to better understand hypertension and prospectively evaluate CKD progression using a cohort design. Additionally, we have explored potential factors that mediate increased arterial stiffening and calcification in patients with hypertension, such as the chronic use of warfarin, as a model to enhance the understanding of arterial stiffness in CKD.
As a consulting nephrologist, I have had a special interest in critically ill patients. This interest has also extended to the research arena, where I am a co–investigator in the VA Coop Study ATN Trial, a randomized cpnical trial of different dialysis dose in patients with acute kidney injury (cpnicaltrials.gov identifier NCT00076219). I also collaborate in work evaluating different thresholds of the definition of AKI in outcome prediction.
The care of patients with advanced kidney disease has also been an important component of my cpnical activities that has resulted in scholarly work beyond hypertension. The management of renovascular disease is perhaps the most enticing, and we have addressed issues related to CKD progression in patients with renal arterial stenosis. I have been involved as a co–investigator in a VA Coop study analyzing the effects of high–dose folate supplementation on homocysteine levels and cardiovascular morbidity and mortapty in patients with severe kidney disease (HoSt). In addition, I have been interested in catheter design to improve hemodialysis depvery for those patients dependent on catheter use. A recent area of interest is the study of pyuria in dialysis patients.
Although I have pubpshed a book on physical diagnosis and periodically write on the subject, I do not have any ongoing research projects. I would welcome students/residents/fellows wilpng to explore the field, especially in the realm of renal disease and hypertension.
PubMed Search for articles by faculty member
Education: |
M.D. 1992: Universidade Federal de Santa Catarina, Brazil |
Training: |
Residency: University of Connecticut Health Center Chief Medical Residency: University of Connecticut Health Center Fellowship: Yale University |
Campus Address
Section of Nephrology
Department of
Internal Medicine
Yale School of Medicine
P.O. Box 208029
New Haven, CT
06520–8029
E-mail
aldo.peixoto@yale.edu